LatestGoods & Service Tax (GST) 30 September 2026
GST Authority Upholds ₹4.6 Cr ITC Claim Against Aurobindo Pharma
Telangana’s GST appellate authority upheld the order that Aurobindo Pharma must reverse an excess input tax credit of about ₹4.6 crore. The ruling reinforces strict GST compliance, confirming the company’s liability to forfeit the claimed credit.
GST appellate authority upholds ₹4.6 crore ITC reversal for Aurobindo Pharma
- Telangana’s GST appellate body confirmed the order requiring Aurobindo Pharma to forfeit an excess input tax credit of about ₹4.6 crore.
- The decision stresses strict adherence to GST rules and signals heightened scrutiny on tax credit claims.
Need help understanding this update?
Connect with our domain experts instantly via WhatsApp for customized legal guidance.
